BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dualis H, Zefong AC, Joo LK, Dadar Singh NK, Syed Abdul Rahim SS, Avoi R, Jeffree MS, Hassan MR, Ibrahim MY, Omar A. Factors and outcomes in Severe Fever with Thrombocytopenia Syndrome (SFTS): A systematic review. Ann Med Surg (Lond) 2021;67:102501. [PMID: 34188913 DOI: 10.1016/j.amsu.2021.102501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoo JR, Lee KH, Kim M, Oh HJ, Heo ST. Tocilizumab therapy for IL-6 increment in a patient with non-fatal severe fever with thrombocytopenia syndrome. Int J Infect Dis 2022:S1201-9712(22)00389-7. [PMID: 35803471 DOI: 10.1016/j.ijid.2022.06.058] [Reference Citation Analysis]
2 Wang Y, Song Z, Wei X, Yuan H, Xu X, Liang H, Wen H. Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis. PLoS Negl Trop Dis 2022;16:e0010489. [DOI: 10.1371/journal.pntd.0010489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]